GlobeNewswire

SolarWinds Showcases Network Management Portfolio Breakthroughs at Cisco Live 2018

Dela

Network Insight(TM) for Cisco Nexus® simplifies the management of complex networks, while intelligent mapping supports hybrid IT environments four times larger than previous generation

AUSTIN, Texas, June 11, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a worldwide leader in network management software, today announced its participation at Cisco Live!®, June 10-14, 2018, in Orlando, Florida. For the first time, the company will publicly exhibit the latest updates to its network management product portfolio, demonstrating the ability to support networks up to four times larger than the previous generation, and how deeper visibility helps IT professionals scale up and support larger data center networks as workloads increase, or scale out to address complex distributed networks. SolarWinds believes the broad refresh, built on the Orion® Platform, strengthens its IDC®-validated network management leadership position.1

"Time is a critical company asset that is becoming increasingly more challenging to manage in a hybrid IT environment," said Christoph Pfister, executive vice president of products, SolarWinds. "Our goal is to arm technology professionals with the right tools, regardless of the size of their organization, so they are able to do more with less-identify problems more quickly and solve network issues with fewer resources, so that eventually they have enough breathing room to take the necessary steps to optimize performance and scale up and out when they are ready."

"In the past, we have been using over 12 different items to track our inventory, to manage our systems, to see how the network is overall performing, and it got to be a pain to know which one to go to, what spreadsheet to even go to," said Allen Gray, senior network engineer, Cooper Standard Automotive, a leading global supplier of systems and components for the automotive industry. "It has saved me time, made us more efficient in our operations, to be able to do other things, and be more proactive versus reactive." Watch video here.

Think Tank Session and In-Booth Presentations

Attendees will have the opportunity to participate in sessions hosted by SolarWinds Head Geeks(TM) Patrick Hubbard, Destiny Bertucci, and Leon Adato at booth 1259, where fully licensed copies of SolarWinds Network Performance Monitor Network Configuration Manager NetFlow Traffic Analyzer Server & Application Monitor and Log Manager for Orion will be given away to qualifying attendees, while supplies last.

Network Ops: Bigger and Badder

  • Who: Patrick Hubbard
  • What: This Think Tank session covers how SolarWinds continues to meet the challenges of expanding monitoring demands. Learn best practices developed by some of the most advanced of SolarWinds' 250,000 customers on how to maintain-or even recover-observability as networks simultaneously grow larger and more complex, while demanding more specialized tools.
  • When:
    · Monday, June 11, 6:30 p.m. - 7:00 p.m. EDT
  • Where: World of Solutions, Think Tank #2
  • Booth 1259 Presentations:
    · Monday, June 11, 11:00 a.m. -  11:30 a.m. EDT
    · Tuesday, June 12, 3:00 p.m. - 3:30 p.m. EDT
    · Wednesday, June 13, 2:00 p.m. - 2:30 p.m. EDT
    · Thursday, June 14, 11:00 a.m. - 11:30 a.m. EDT

Network Insight Expanded: Tame the Most Complex Technologies on Your Network

  • Who: Destiny Bertucci
  • What: Learn how to dig into new hardware details and make troubleshooting easier in this discussion on extracting deep insight from your F5® BIG-IP® load balancers, Cisco® ASAs, and Cisco Nexus NX-OS VDC capable devices.
  • When:
    · Monday, June 11, 3:00 p.m. - 3:30 p.m. EDT
    · Tuesday, June 12, 2:00 p.m. - 2:30 p.m. EDT
    · Wednesday, June 13, 3:00 p.m. - 3:30 p.m. EDT
  • Where: Booth 1259

Solving for Scalability: Design Techniques for Growing Networks and the Monit oring Tools That Love Them

  • Who: Leon Adato
  • What: Remember when your network was little? Of course you don't; it was never little! Gain valuable insight about how to leverage your existing monitoring tools to scale for the technological challenges of tomorrow.
  • When:
    · Monday, June 11, 2:00 p.m. - 2:30 p.m. EDT
    · Tuesday, June 12, 11:00 a.m. - 11:30 a.m. EDT
    · Wednesday, June 13, 11:00 a.m. - 11:30 a.m. EDT
  • Where: Booth 1259

New Versions across the Network Management Portfolio

Within its network management portfolio, SolarWinds announced updates to the following software products.

  • Network Performance Monitor (NPM) 12.3 - Along with Network Insight for Cisco Nexus, including detailed visibility into virtual port channels (vPCs), the latest version of NPM provides superior network monitoring capabilities and detailed visibility for multi-vendor environments.
     
  • Network Configuration Monitor (NCM) 7.8 - The updated version brings even stronger automation and control of network functions and, like NPM, adds Network Insight for Cisco Nexus switches. It provides configuration snippets and the ability to filter, search, and view access control lists (ACLs), including object groups, and virtual device context (VDC) support. 
     
  • IP Address Manager (IPAM) 4.7 - A valuable tool that automates management of IP addresses, the latest version now automates IP requests and monitors hybrid environments with Amazon® Route53 and Azure® DNS support.
     
  • NetFlow Traffic Analyzer (NTA) 4.4 - With a new Flow Storage SQL database at its foundation and less-demanding CPU and IOPS requirements, the new version offers IT professionals significantly improved speed and performance in identifying network traffic issues and removing bottlenecks, while providing better security.
     
  • VoIP & Network Quality Manager (VNQM) 4.5 - The latest version of VNQM adds support for monitoring of SIP trunks, enabling users to manage voice quality and performance across networks using the latest VoIP technologies.

Additional Resources

Connect with SolarWinds

1 Source: IDC-defined Network Management Software functional market. IDC's Worldwide Semiannual Software Tracker®, April 2018

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as a worldwide leader in both network management software and MSP solutions. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:
Nicole Fachet
Text100
Phone: 212.871.3950
NicoleF@text100.com

Alex Navarro
SolarWinds
Phone: 512.498.6388
pr@solarwinds.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum